Imsidolimab (ANB 019) is a humanized anti-IL-36R monoclonal antibody that inhibits IL-36 signaling and can be used to study systemic pustular psoriasis.
Purity:
95.00%
CAS Number:
[2102543-86-0]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted